Status:
COMPLETED
Venous Disease Thromboembolic and Amyotrophic Lateral Sclerosis
Lead Sponsor:
University Hospital, Brest
Conditions:
Lateral Amyotrophic Sclerosis
Venous Thrombo-embolic Desease
Eligibility:
All Genders
Brief Summary
Venous thrombo-embolic (VTE) rates could be high in patients with amyotrophic lateral sclerosis (ALS). Indeed, the rate of VTE in this specific population could be 7-fold higher in this population. Pr...
Eligibility Criteria
Inclusion
- patients with amyotrophic lateral sclerosis defined by revised El Escorial score criteria followed in competence centre of Brest Universitary Hospital during 2000 to 2019
Exclusion
- no consent
- other neuro-degenerativ diseases
Key Trial Info
Start Date :
March 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2020
Estimated Enrollment :
227 Patients enrolled
Trial Details
Trial ID
NCT04446325
Start Date
March 1 2020
End Date
May 1 2020
Last Update
September 11 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHRU de Brest
Brest, France, 29200